Clinical Trials Browser

Terminated × Head and Neck Neoplasms × Oxaliplatin × Clear all

NCT00591149 2017-06-14

Oxaliplatin and Docetaxel Followed by Cetuximab for Head and Neck Cancer

Phase 2 Terminated

16 enrolled 5 charts

Carcinoma, Squamous Cell, Head and Neck Neoplasms, Neoplasms, Neoplasms, Squamous Cell

NCT00101075 2017-02-27

Title XELOX FOR SALIVARY GLAND CANCERS

Phase 2 Terminated

Head and Neck Neoplasms, Salivary Gland Neoplasms

NCT00256295 2017-02-01

Weekly Oxaliplatin and Gemcitabine for Recurrent or Metastatic Head and Neck Cancer

Phase 2 Terminated

8 enrolled 7 charts

Head and Neck Neoplasms